Next Article in Journal
Immunogenicity after Second ChAdOx1 nCoV-19 (AZD1222) Vaccination According to the Individual Reactogenicity, Health Status and Lifestyle
Next Article in Special Issue
Evaluation of Commercial Myxomatosis Vaccines against Recombinant Myxoma Virus (ha-MYXV) in Iberian Hare and Wild Rabbit
Previous Article in Journal
Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies
Previous Article in Special Issue
Safety and Efficacy of the East Coast Fever Muguga Cocktail Vaccine: A Systematic Review
 
 
Article

Article Versions Notes

Vaccines 2021, 9(12), 1472; https://doi.org/10.3390/vaccines9121472
Action Date Notes Link
article xml file uploaded 13 December 2021 11:40 CET Original file -
article xml uploaded. 13 December 2021 11:40 CET Update -
article pdf uploaded. 13 December 2021 11:40 CET Version of Record https://www.mdpi.com/2076-393X/9/12/1472/pdf-vor
article supplementary file uploaded. 13 December 2021 11:40 CET - https://www.mdpi.com/2076-393X/9/12/1472#supplementary
article html file updated 13 December 2021 11:41 CET Original file -
article xml file uploaded 14 December 2021 10:18 CET Update -
article xml uploaded. 14 December 2021 10:18 CET Update https://www.mdpi.com/2076-393X/9/12/1472/xml
article pdf uploaded. 14 December 2021 10:18 CET Updated version of record https://www.mdpi.com/2076-393X/9/12/1472/pdf
article html file updated 14 December 2021 10:24 CET Update -
article html file updated 30 July 2022 21:58 CEST Update https://www.mdpi.com/2076-393X/9/12/1472/html
Back to TopTop